TrialDiabetes care2011

Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trial.

Michael A Nauck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.